Loading stock data…
Loading stock data…
US$1.51
Get one email when SXTP crosses your level. Checked every 15 minutes during market hours.
▼ -0.01 (-0.66%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
45.0
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.01
Bearish momentumMACD below its signal line (0.00).
50-day average
1.53
Price belowShort-term trend reference.
200-day average
2.97
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
60 Degrees Pharmaceuticals Inc. is a specialty pharmaceutical company dedicated to developing and commercializing medicines for the treatment and prevention of vector-borne and infectious diseases. Its primary product, ARAKODA (tafenoquine), is an FDA-approved antimalarial for malaria prophylaxis in adults 18 years and older, featuring a dosing regimen with a loading phase, weekly doses during exposure, and a final dose post-travel, available through prescription in the United States and Austral…
www.60degreespharma.com2 strong buy · 4 buy · 2 hold · 0 sell · 0 strong sell (8 analysts, 2026-07-01)
2 strong buy · 4 buy · 2 hold · 0 sell · 0 strong sell (8 analysts, 2026-06-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-05-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-07-15 | 1.52 | 1.64 | ✓ Beat |
| 2026-05-13 | 0.03 | 0.05 | ✓ Beat |
| 2026-03-30 | -2 | -8.17 | ✗ Miss |
| 2025-11-10 | 13.81 | 13.1 | ✗ Miss |
| 2025-08-13 | -4.96 | -4.33 | ✓ Beat |
| 2025-05-15 | -1.31 | -1.56 | ✗ Miss |
Companies in the same industry, via Finnhub